Anetumab ravtansine

DB14809InvestigationalProtein Based Therapies

Anetumab ravtansine is under investigation in clinical trial NCT03455556 (Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer).

Mechanism: Pharmacologically active on Mesothelin
Curator reviewed
Code names: BAY 94-9343

Resolves to

Compound

UNIIM170940PMICAS1375258-01-7

Targets

Q13421MSLN

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

12Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Anetumab ravtansine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account